Literature DB >> 3499984

In vitro generation of tumour-specific lymphocyte reactivity to colonic carcinoma cells. Comparison with normal colonic mucosa cells.

M Kuppner1, S Wilkinson, E Casson, O Eremin.   

Abstract

Purified tumour cells and normal mucosa cells from fresh human colorectal cancer resection specimens, and T-cell-enriched autologous peripheral blood lymphocytes, were mixed in short-term (6 day) mixed lymphocyte-tumour cell (MLTC) microcultures. Lymphocyte stimulation was measured by 3H-thymidine uptake, and a stimulation index (SI = [lymphocytes vs tumour cells (cpm)-tumour cells (cpm)]/[lymphocytes (cpm)] greater than 3 was regarded as significant. Significant lymphocyte reactivity was found in 10/15 patients with colon carcinoma. However, 1 patient with autologous tumour reactivity, also showed significant stimulation against autologous normal mucosa cells, suggesting tumour-associated reactivity. Maximum stimulation occurred most frequently at a lymphocyte:tumour cell ratio of 2:1 and with nylon wool-passaged lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499984     DOI: 10.1007/BF00199149

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Lymphocyte blastogenesis induced by autochthonous human solid tumor cells: relationship to stage of disease and serum factors.

Authors:  G M Mavligit; E M Hersh; C M McBride
Journal:  Cancer       Date:  1974-11       Impact factor: 6.860

2.  Tumour-distinctive cellular immunity to renal carcinoma.

Authors:  J Stjernswärd; L E Almgård; S Franzén; T von Schreeb; L B Wadström
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

3.  Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.

Authors:  F Vánky; J Willems; A Kreicbergs; T Aparisi; M Andréen; L A Broström; U Nilsonne; E Klein; G Klein
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  T and B lymphocyte populations in human normal lymph node, regional tumour lymph node and inflammatory lymph node.

Authors:  O Eremin; D Plumb; R R Coombs
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

5.  Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.

Authors:  A Uchida; E Klein
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

6.  Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.

Authors:  J E de Vries; H Spits
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.

Authors:  A Uchida; M Moore
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity.

Authors:  F T Vánky; B M Vose; M Fopp; E Klein
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

9.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

View more
  2 in total

1.  Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.

Authors:  M Radrizzani; M Quaia; B Benedetti; S Andreola; M Vaglini; E Galligioni; G Fossati; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Tumour-associated proliferative responses in vitro of regional lymph nodes draining solid cancers in man.

Authors:  T Mainou-Fowler; O Eremin
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.